This CTNNB1 gene mutation has been associated with the inflammatory subtype of tumor hepatocytes, which is characterized by an over expression of acute phase inflammatory proteins like CRP and serum amyloid A (SAA) and the consequent constitutive activation of the IL6/JAK/STAT pathway. This evidence concerns the gene IL6 and neoplasm.